|
| | Publication Year | Title | Author(s) |
| 501 | 30-Jul-2022 | Plasma high-density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. | Pedrini, Steve; Doecke, James D; Hone, Eugene; Wang, Penghao; Thota, Rohith; Bush, Ashley I; Rowe, Christopher C ; Doré, Vincent ; Villemagne, Victor L ; Ames, David; Rainey-Smith, Stephanie; Verdile, Giuseppe; Sohrabi, Hamid R; Raida, Manfred R; Taddei, Kevin; Gandy, Sam; Masters, Colin L ; Chatterjee, Pratishtha; Martins, Ralph N |
| 502 | 2022 | Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline. | Fowler, Christopher J; Stoops, Erik; Rainey-Smith, Stephanie R; Vanmechelen, Eugeen; Vanbrabant, Jeroen; Dewit, Nele; Mauroo, Kimberley; Maruff, Paul; Rowe, Christopher C ; Fripp, Jurgen; Li, Qiao-Xin; Bourgeat, Pierrick; Collins, Steven J; Martins, Ralph N; Masters, Colin L ; Doecke, James D |
| 503 | 5-Apr-2022 | Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum. | Doré, Vincent ; Doecke, James D; Saad, Ziad S; Triana-Baltzer, Gallen; Slemmon, Randy; Krishnadas, Natasha ; Bourgeat, Pierrick; Huang, Kun ; Burnham, Samantha; Fowler, Christopher; Rainey-Smith, Stephanie R; Bush, Ashley I; Ward, Larry; Robertson, Jo; Martins, Ralph N; Masters, Colin L ; Villemagne, Victor L ; Fripp, Jurgen; Kolb, Hartmuth C; Rowe, Christopher C |
| 504 | Feb-2019 | A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. | Ashton, Nicholas J; Nevado-Holgado, Alejo J; Barber, Imelda S; Lynham, Steven; Gupta, Veer; Chatterjee, Pratishtha; Goozee, Kathryn; Hone, Eugene; Pedrini, Steve; Blennow, Kaj; Schöll, Michael; Zetterberg, Henrik; Ellis, Kathryn A; Bush, Ashley I; Rowe, Christopher C ; Villemagne, Victor L ; Ames, David; Masters, Colin L ; Aarsland, Dag; Powell, John; Lovestone, Simon; Martins, Ralph; Hye, Abdul |
| 505 | 9-Jun-2020 | Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology. | Ashraf, Azhaar; Ashton, Nicholas J; Chatterjee, Pratishtha; Goozee, Kathryn; Shen, Kaikai; Fripp, Jurgen; Ames, David; Rowe, Christopher C ; Masters, Colin L ; Villemagne, Victor L ; Hye, Abdul; Martins, Ralph N; So, Po-Wah |
| 506 | 19-Dec-2018 | A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. | Porter, Tenielle; Burnham, Samantha C; Savage, Greg; Lim, Yen Ying; Maruff, Paul; Milicic, Lidija; Peretti, Madeline; Ames, David; Masters, Colin L ; Martins, Ralph N; Rainey-Smith, Stephanie R; Rowe, Christopher C ; Salvado, Olivier; Taddei, Kevin; Groth, David; Verdile, Giuseppe; Villemagne, Victor L ; Laws, Simon M |
| 507 | 2-Jan-2024 | Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework. | Korde, Aruna; Patt, Marianne; Selivanova, Svetlana V; Scott, Andrew M ; Hesselmann, Rolf; Kiss, Oliver; Ramamoorthy, Natesan; Todde, Sergio; Rubow, Sietske M; Gwaza, Luther; Lyashchenko, Serge; Andersson, Jan; Hockley, Brian; Kaslival, Ravindra; Decristoforo, Clemens |
| 508 | Jan-2016 | Positron Emission Tomographic Imaging in Stroke: Cross-Sectional and Follow-Up Assessment of Amyloid in Ischemic Stroke. | Sahathevan, Ramesh; Linden, Thomas; Villemagne, Victor L ; Churilov, Leonid ; Ly, John V; Rowe, Christopher C ; Donnan, Geoffrey A ; Brodtmann, Amy |
| 509 | 1-Oct-2002 | Positron emission tomography and epilepsy. | Casse, Rey; Rowe, Christopher C ; Newton, Mark R; Berlangieri, Salvatore U ; Scott, Andrew M |
| 510 | 18-Oct-2008 | Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study. | Scott, Andrew M ; Gunawardana, Dishan H; Wong, Joseph; Kirkwood, Ian; Hicks, Rodney J; Ho Shon, Ivan; Ramshaw, Jayne E; Robins, Peter |
| 511 | 1-Jul-2004 | Positron emission tomography scanning in the assessment of patients with lymphoma. | Foo, S S; Mitchell, Paul L R ; Berlangieri, Salvatore U ; Smith, C L; Scott, Andrew M |
| 512 | 5-May-2005 | Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer. | Yap, Kelvin K; Byrne, Amanda J; Berlangieri, Salvatore U ; Poon, Aurora M T ; Mitchell, Paul L R ; Knight, Simon R ; Clarke, Peter C; Harris, Anthony H; Tauro, Andrew; Rowe, Christopher C ; Scott, Andrew M |
| 513 | 16-Jan-2024 | Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies. | Lee, Sze Ting ; Kovaleva, Natalia; Senko, Clare ; Kee, Damien ; Scott, Andrew M |
| 514 | 1-Oct-1992 | Postictal switch in blood flow distribution and temporal lobe seizures. | Newton, Mark R; Berkovic, Samuel F ; Austin, M C; Rowe, Christopher C ; McKay, W J; Bladin, Peter F |
| 515 | Mar-2016 | Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. | Dubois, Bruno; Hampel, Harald; Feldman, Howard H; Scheltens, Philip; Aisen, Paul; Andrieu, Sandrine; Bakardjian, Hovagim; Benali, Habib; Bertram, Lars; Blennow, Kaj; Broich, Karl; Cavedo, Enrica; Crutch, Sebastian; Dartigues, Jean-François; Duyckaerts, Charles; Epelbaum, Stéphane; Frisoni, Giovanni B; Gauthier, Serge; Genthon, Remy; Gouw, Alida A; Habert, Marie-Odile; Holtzman, David M; Kivipelto, Miia; Lista, Simone; Molinuevo, José-Luis; O'Bryant, Sid E; Rabinovici, Gil D; Rowe, Christopher C ; Salloway, Stephen; Schneider, Lon S; Sperling, Reisa; Teichmann, Marc; Carrillo, Maria C; Cummings, Jeffrey; Jack, Cliff R |
| 516 | 18-Jul-2018 | Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice. | Zeitelhofer, Manuel; Li, Hong; Adzemovic, Milena Z; Nilsson, Ingrid; Muhl, Lars; Scott, Andrew M ; Eriksson, Ulf |
| 517 | 13-Sep-2016 | Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up | Burnham, Samantha C; Rowe, Christopher C ; Baker, David; Bush, Ashley I; Doecke, James D; Faux, Noel G; Laws, Simon M; Martins, Ralph N; Maruff, Paul; Macaulay, S Lance; Rainey-Smith, Stephanie R; Savage, Greg; Ames, David; Masters, Colin L ; Wilson, William; Villemagne, Victor L |
| 518 | 1-Dec-2013 | Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. | Rowe, Christopher C ; Bourgeat, Pierrick; Ellis, Kathryn A; Brown, Belinda; Lim, Yen Ying; Mulligan, Rachel S ; Jones, Gareth; Maruff, Paul; Woodward, Michael M ; Price, Roger; Robins, Peter; Tochon-Danguy, Henri; O'Keefe, Graeme J; Pike, Kerryn E; Yates, Paul; Szoeke, Cassandra; Salvado, Olivier; Macaulay, S Lance; O'Meara, Timothy; Head, Richard; Cobiac, Lynne; Savage, Greg; Martins, Ralph N; Masters, Colin L ; Ames, David; Villemagne, Victor L |
| 519 | 8-Jul-2021 | Predicting primary treatment failure using interim FDG-PET scanning in Diffuse large B-cell lymphoma. | Wight, Joel C ; Wai, Shin Hnin; Shen, Edward; Lee, Sze Ting ; Berlangieri, Salvatore U ; Fancourt, Tineke ; Hawkes, Eliza A ; Hannah, Anthony; Leung, Teresa; Chong, Geoffrey |
| 520 | 2013 | Prediction of amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests. | Bahar-Fuchs, Alex; Villemagne, Victor L ; Ong, Kevin; Chetélat, Gaël; Lamb, Fiona ; Reininger, Cornelia B; Woodward, Michael M ; Rowe, Christopher C |
